CombiGene AB (publ)

CombiGene AB (publ)verified

COMBI.ST

Price:

$2.47

Market Cap:

$48.91M

CombiGene AB (publ) engages in the development of gene therapy for severe life-altering diseases in Sweden. The company is developing two gene therapy candidates, including CG01, which is in preclinical studies for the treatment of epilepsy and biodistribution and toxicology studies; and CGT2 for the treatment of lipodystrophy. The company has a licensing and collaboration agreement with Lipigon Pharmaceuticals AB to develop a gene therapy treatment for partial lipodystrophy; and with Spark Therapeutics to develop adeno-associated virus (AAV) based gene therapies. CombiGene AB (publ) was founded in 1999 and is headquartered in Lidingö, Sweden.

Industry

Biotechnology

IPO Date

2015-05-25

Stock Exchange

STO

Ticker

COMBI.ST

The Current Ratio as of December 2025 (TTM) for CombiGene AB (publ) (COMBI.ST) is 17.47

According to CombiGene AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 17.47. This represents a change of 15.05% compared to the average of 15.18 of the last 4 quarters.

CombiGene AB (publ) (COMBI.ST) Historical Current Ratio (quarterly & annually)

How has COMBI.ST Current Ratio performed in the past?

The mean historical Current Ratio of CombiGene AB (publ) over the last ten years is 11.62. The current 17.47 Current Ratio has changed 14.93% with respect to the historical average. Over the past ten years (40 quarters), COMBI.ST's Current Ratio was at its highest in in the September 2015 quarter at 47.32. The Current Ratio was at its lowest in in the March 2020 quarter at 0.54.

Quarterly (TTM)
Annual

Average

11.62

Median

10.50

Minimum

0.80

Maximum

24.84

CombiGene AB (publ) (COMBI.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of CombiGene AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 763.92%

Maximum Annual Current Ratio = 24.84

Minimum Annual Increase = -67.81%

Minimum Annual Current Ratio = 0.80

Quarterly (TTM)
Annual
YearCurrent RatioChange
202417.47-29.68%
202324.848.83%
202222.8325.36%
202118.21162.48%
20206.94763.92%
20190.80-64.82%
20182.28-46.30%
20174.25-6.11%
20164.53-67.81%
201514.0651.60%

CombiGene AB (publ) (COMBI.ST) Average Current Ratio

How has COMBI.ST Current Ratio performed in the past?

The current Current Ratio of CombiGene AB (publ) (COMBI.ST) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

21.71

5-year avg

18.06

10-year avg

11.62

CombiGene AB (publ) (COMBI.ST) Current Ratio vs. Peers

How is COMBI.ST’s Current Ratio compared to its peers?

CombiGene AB (publ)’s Current Ratio is greater than FRISQ Holding AB (publ) (2.40), greater than Kancera AB (publ) (8.02), greater than Emplicure AB (publ) (3.52), greater than RLS Global AB (publ) (3.63), greater than Amniotics AB (publ) (1.17), greater than Idogen AB (publ) (1.67), greater than Pharmiva AB (publ) (5.46), greater than Cline Scientific AB (publ) (1.91), greater than Diagonal Bio AB (publ) (1.94), greater than Ziccum AB (publ) (0.36),

Build a custom stock screener for CombiGene AB (publ) (COMBI.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CombiGene AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CombiGene AB (publ) (COMBI.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CombiGene AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is CombiGene AB (publ)'s Current Ratio?

How is the Current Ratio calculated for CombiGene AB (publ) (COMBI.ST)?

What is the highest Current Ratio for CombiGene AB (publ) (COMBI.ST)?

What is the 3-year average Current Ratio for CombiGene AB (publ) (COMBI.ST)?

What is the 5-year average Current Ratio for CombiGene AB (publ) (COMBI.ST)?

How does the current Current Ratio for CombiGene AB (publ) (COMBI.ST) compare to its historical average?